Drug · DIN 02521083
OPSYNVI
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 25, 2021; first marketed November 25, 2021.
- Drug Identification Number (DIN)
- 02521083
- Company (DIN owner)
- Janssen Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Macitentan and tadalafil C02KX54
- Class
- Human
- Record last updated
- April 16, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| MACITENTAN | 10 MG | |
| TADALAFIL | 40 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 14, 2021: NOC 26835New Drug Submission (NDS)